How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q2 2022?

58 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q2 2022. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 27,995,500
Total 13F shares: 35,563,928
Share change: -9,010,846
Total reported value: $34,226,317
Price per share: $0.96
Number of holders: 58
Value change: -$9,550,880
Number of buys: 26
Number of sells: 57

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 87184Q107:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bain Capital Life Sciences Investors, LLC	13F	Company	22%	6,264,420	$7,455,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	20%	5,526,376	$6,576,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	15%	4,170,141	$4,963,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	13%	3,500,000	$4,165,000	—	31 Mar 2022	13F
Ally Bridge Group (NY) LLC	13F	Company	12%	3,364,895	$4,004,000	—	31 Mar 2022	13F
Flagship Pioneering, LLC	13F	Company	10%	2,938,494	$3,497,000	—	31 Mar 2022	13F
Omega Fund Management, LLC	13F	Company	9%	2,512,705	$2,990,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	8.1%	2,255,530	$2,685,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	6.8%	1,900,000	$2,261,000	—	31 Mar 2022	13F
Samsara BioCapital, LLC	13F	Company	6.8%	1,899,616	$2,261,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	4.1%	1,139,351	$1,356,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	3.5%	985,231	$1,172,000	—	31 Mar 2022	13F
Sio Capital Management, LLC	13F	Company	3.2%	902,907	$1,074,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.9%	818,962	$975,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	2.1%	584,272	$695,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.8%	511,824	$609,000	—	31 Mar 2022	13F
LGT CAPITAL PARTNERS LTD.	13F	Company	1.8%	500,000	$595,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	1.7%	487,083	$579,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	1.3%	372,208	$443,000	—	31 Mar 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.89%	249,473	$297,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.86%	240,239	$286,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.79%	221,071	$263,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.77%	216,602	$257,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.68%	190,319	$227,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.67%	186,366	$222,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.65%	183,253	$202,000	—	31 Mar 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.61%	170,000	$202,000	—	31 Mar 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.49%	137,156	$163,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.46%	128,102	$152,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.45%	126,988	$152,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.44%	121,809	$145,000	—	31 Mar 2022	13F
LPL Financial LLC	13F	Company	0.43%	121,135	$144,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.38%	106,700	$127,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.32%	88,811	$106,000	—	31 Mar 2022	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.31%	85,900	$102,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.29%	82,354	$97,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.29%	81,891	$97,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.29%	80,884	$96,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.29%	80,477	$95,000	—	31 Mar 2022	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.28%	78,535	$93,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.23%	63,865	$76,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.23%	63,000	$75,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	0.2%	56,088	$67,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.19%	52,800	$63,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.16%	45,000	$54,000	—	31 Mar 2022	13F
XTX Topco Ltd	13F	Company	0.16%	44,555	$53,000	—	31 Mar 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	39,743	$47,000	—	31 Mar 2022	13F
ACT CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	35,000	$42,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.12%	34,537	$41,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.12%	34,216	$41,000	—	31 Mar 2022	13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2022

As of 30 Jun 2022, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,563,928 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, Artal Group S.A., Ally Bridge Group (NY) LLC, Flagship Pioneering Inc., VANGUARD GROUP INC, FMR LLC, Omega Fund Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Samsara BioCapital, LLC, and BlackRock Inc.. This page lists 58 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-28

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.